相关实验视频
Updated: May 8, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.3K
在频繁恶化的喘中血清细胞因子模式的表征:对于表型和管理的含义
Dao Ngoc Bang1, Pham Dac The2, Pham Thi Kim Nhung1
1Respiratory Center, Military Hospital 103, Vietnam Military Medical University, Hanoi 12100, Vietnam.
Advances in respiratory medicine
|December 27, 2024
概括
患有频繁喘恶化症的患者具有更高的互白素-4 (IL-4) 和互白素-13 (IL-13) 水平. 这种独特的细胞因子配置可能有助于识别患有严重喘发作高风险的个体.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 生物化学 生物化学
背景情况:
- 喘恶化是临床关键事件.
- 常见的恶化剂中的炎症机制和细胞因子概况尚未完全理解.
研究的目的:
- 为了比较喘患者的血清细胞因子度,频繁的恶化与不频繁的恶化.
- 识别与频繁喘恶化相关的特定细胞因子特征.
主要方法:
- 对120名稳定的喘患者进行了前性,横截面研究.
- 对八种关键细胞因子 (IL-4,IL-12,IL-13,IL-17,IFN-α,IFN-γ,TNF-α和IL-1β) 的血清度进行比较.
- 分层分为频繁 (≥2次恶化/年) 和不频繁 (1次恶化/年) 的恶化组.
主要成果:
- 常见的恶化症状显示血清IL-4和IL-13水平显著上升 (p <0.05).
- 过敏病史和并发症 (慢性鼻炎,GERD,OSA) 在频繁恶化症 (p <0.05) 中的患病率增加.
- 观察到IgE水平与IFN-α/TNF-α之间的相关性,以及FeNO水平与IL-17/IL-1β之间的相关性 (所有p <0.05).
结论:
- 一种明显的细胞因子特征,标志着IL-4和IL-13的升高,是常见的喘恶化症的特征.
- 细胞因子与生物标志物的相关性表明了恶化易感性的机制.
- 这些发现可以指导高风险喘患者的向治疗.
更多相关视频
相关概念视频
01:20Asthma: Pathogenesis and Management
224
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
224
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:30Asthma-IV: Diagnostic and Management
2.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.4K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
150
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
150
01:17Drugs Used in Lower Respiratory Disorders: Overview
241
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
241